Press Releases

Press Releases

This page contains links to a selection of notices sent to the public and media outlets that were written by members of the FLCCC team.

May 10, 2022
FLCCC Recognizes New Legislation in New Hampshire to Allow Ivermectin OTC
If the legislation is signed into law by the Governor, residents aged 18 and over will have access to ivermectin through a pharmacy without a prescription. FLCCC co-founder and world-renowned intensive care specialist, Paul Marik, MD recently testified before the N.H. legislature to support access to needed medications and to protect the doctor-patient relationship.
“I was honored to be asked to provide testimony to the New Hampshire legislature on this important legislation,” said Marik. “My hope is that the governor will sign the bill and it will become law, allowing many more people to have access to a medication that we know to be very well tolerated and has helped so many people.”

Mar 18, 2022
FLCCC responds to Wall Street Journal article on results of TOGETHER TRIAL
The results of this trial, which was predetermined to show ivermectin as ineffective, affirms the need for early treatment against COVID-19 and confirms that conflicted groups continue to influence competitor trials.

Mar 18, 2022
State of Virginia recognizes Dr. Marik for distinguished career and life-saving work during COVID

The Commending Resolution, which honors members of the Commonwealth for their service and contributions to the state of Virginia, passed by unanimous vote.

Jan 11, 2022
Dr. Marik Withdraws Lawsuit Against Sentara Healthcare
Statement on Dr. Paul Marik’s voluntary withdrawal of lawsuit against Sentara Healthcare.

Nov 17, 2021
 Marik vs Sentara—The Right To Treat Hearing
Hearing Date and Time: Thurs., Nov. 18 at 1pm ET
After filing a complaint in the Circuit Court for the City of Norfolk, Virginia on November 9, 2021 (Case #CL21013852), Paul Marik, MD, one of the most highly published critical care physicians in the world and the Director of the ICU at Sentara Norfolk General Hospital will be given his day in court. The hearing set for Thursday, November 18, could lead to the reinstatement of several treatments that are currently banned by the Sentara Healthcare System.
Read full release

Nov 9, 2021
 Dr. Paul Marik: “Patients at Sentara Norfolk General Hospital are Dying Needlessly.”
Lawsuit filed as hospital handcuffs doctors’ ability to save dying COVID-19 patients.

In a press release issued today, the FLCCC announced that its Co-Chief Medical Officer, Dr. Paul Marik filed suit against Sentara Healthcare System for instituting a policy preventing him and other physicians from administering proven, life-saving treatments. “We take an oath as doctors to do no harm,” said Dr. Pierre Kory, Co-Chief Medical Officer of the FLCCC. “No doctor should be forced to watch their patient die knowing that more could have been done to save them.”

Nov 9, 2021
 World’s Leading ICU Doctor Files Lawsuit Against Hospital System After Being Barred from Administering Safe and Effective COVID-19 Treatments
A Virginia Physician has been prohibited from using safe and time-honored medications in hospital while death rates from COVID-19 continue to mount

WASHINGTON, D.C. – Paul Marik, MD, one of the most highly published critical care physicians in the world and the Director of the ICU at Sentara Norfolk General Hospital, was recently told by Sentara Healthcare that he could no longer administer a range of highly effective COVID-19 treatments to critically ill patients—the same treatments he has successfully used to reduce COVID deaths in the ICU by as much as 50%. The result of the prohibition has been a sharp increase in patient mortality. Because Dr. Marik can no longer stand by while patients needlessly die without proper treatment, he has filed a lawsuit to allow him and his colleagues to administer the combination of FDA-approved drugs and other therapies that has saved thousands of critically ill COVID-19 patients in the last 18 months.
Read full statement

Jul 16, 2021
 Statement by the FLCCC & BiRD groups on the retraction of early research on Ivermectin: The Remaining Data Continue to Prove Ivermectin Effective in Preventing and Treating COVID-19.
WASHINGTON, D.C. and BATH, SOMERSET, U.K. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars,
and the British Ivermectin Recommendation Development Group (BIRD), a U.K. based group… Read full statement

Jul 1, 2021
 Joint Statement of the FLCCC & the BiRD Group on the Unethical and Questionable Methods of the Upcoming PRINCIPLE Trial.

Jun 23, 2021
 Ivermectin to be investigated in adults aged 18+ as a possible treatment for COVID-19 in the PRINCIPLE trial
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings. Led by the University of Oxford, PRINCIPLE is investigating treatments for people at more risk of serious illness from COVID-19 which can speed up recovery, reduce the severity of symptoms and prevent the need for hospital admission. To find out more about the study, visit www.principletrial.org

Jun 23, 2021
 The FLCCC Alliance Applauds the Latest Research Which Concluded that Ivermectin Leads to a Massive Reduction in Death Rates in COVID-19

Jun, 2021
 Dr. Kory on the U.S. Deal to Give 1.2 Billion Taxpayer Dollars to Merck for New Drug Instead of Distributing Safe, Effective, Inexpensive Ivermectin.
Also download Statement Transcript

May 3, 2021
 Joint Statement on Widespread Use of Ivermectin in India for Prevention and Early Treatment
The Evidence-Based Medicine Consultancy Ltd (E-BMC Ltd) is a UK-based independent medical research company that contributes to the quality of healthcare globally through the rigorous evaluation of medical evidence to support clinical practice guidelines. Read Full Statement

Apr 29, 2021
 Front Line COVID-19 Critical Care Alliance Statement on New Guidance on Ivermectin from the All India Institute of Medical Science
WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19. Read full statement

Apr 9, 2021
 Front Line COVID-19 Critical Care Alliance Statement on Recent Washington Post Story
WASHINGTON, D.C. – We appreciate the interest from the Washington Post in the use of ivermectin as a safe and effective preventative and treatment for COVID-19. However, the article published yesterday left out several key components of the complete story of how ivermectin is saving lives all over the world. These include the overwhelming amount of data on ivermectin… Read full release

Mar 31, 2021
 FLCCC Alliance Statement on Weak Guidance on Ivermectin from the World Health Organization
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19.

Mar 18, 2021
Leading Experts Discuss the Latest Research on Preventing & Treating COVID-19 with Ivermectin and Call for its Immediate Global Use to End the Pandemic
A group of medical and scientific experts convened by the Front Line COVID-19 Critical Care Alliance (FLCCC) today call for action to put an end to the COVID-19 pandemic by immediately adopting policies that allow for the use of ivermectin in the prevention and treatment of COVID-19.

Mar 9, 2021
FLCCC Alliance Applauds International Group of Medical Experts’ Recognition of Ivermectin as a Safe and Effective Treatment for COVID-19
UK-based panel of leading experts publish their review of the latest research and call for the immediate global adoption of ivermectin to prevent and treat COVID-19 – e-bmc.co.uk.

Mar 7, 2021
FLCCC Alliance Statement on Misleading FDA Guidance on Ivermectin
The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.

Feb 28, 2021
FLCCC Alliance Response to the N.I.H. Guideline Committee Recommendation on Ivermectin use in COVID-19 dated February 11, 2021

Feb 7, 2021
FLCCC Alliance Response to Merck’s Public Statements on Efficacy of Ivermectin in COVID-19
Merck’s assessments of ivermectin’s efficacy in COVID-19 are in striking contrast with the findings reported by multiple expert group’s systematic reviews from across the globe, including metaanalyses of the updated scientific literature […]

Feb 5, 2021
 FLCCC Alliance Response to Dr. Kory’s Senate Testimony Removed by YouTube
YouTube removed the video link of Dr. Pierre Kory’s sworn testimony to the Senate Committee on Homeland Security and Governmental Affairs on official United States business […]

Jan 24, 2021
 FLCCC Alliance Open Letter to the Investigators of the Oxford PRINCIPLE Trial on Ivermectin in COVID‑19
The FLCCC Alliance wishes to raise concerns about the proposed design of the Oxford PRINCIPLE Trial of ivermectin in COVID-19. We believe that it is an ethical imperative to provide those considering participation a truthful account of the available evidence of ivermectin’s efficacy in COVID-19 […

Jan 17, 2021
 FLCCC Alliance Response to the NIH Guideline Committee Recommendation on Ivermectin use in COVID-19 dated January 14th, 2021
The FLCCC considers the Panel’s unwillingness to provide more specific guidance in support of the use of ivermectin in COVID-19 to be severely out of alignment with the known clinical, epidemiological, and observational data. Our detailed response to the Panel’s criticism of the existing evidence base […]

Jan 15, 2021
 Ivermectin is Now a Treatment Option for Health Care Providers
NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19

Jan 7, 2021
 FLCCC Alliance Invited to the NIH COVID-19 Treatment Guidelines Panel to Present Latest Data on Ivermectin
On January 6, 2021, our Drs. Pierre Kory and Paul Marik, founding members of the FLCCC Alliance, appeared before the National Institutes of Health COVID-19 Treatment Guidelines Panel to urge review of current data and an updated NIH guidance.

Dec 22, 2020
New One-page Summary of the Review on Ivermectin in COVID-19
FLCCC Alliance one-page summary of clinical trials showing large magnitude improvements in COVID-19 patients treated with Ivermectin. Related files:
Review on ivermectin in the prophylaxis and treatment of COVID-19  —  One-page Summary of the Review
Please also see our FAQ on Ivermectin in the Treatment of COVID-19

Dec 16, 2020
MATH+ Hospital Treatment Protocol for COVID-19 Now Published (JIC)
FLCCC Alliance peer-reviewed paper published in the Journal of Intensive Care Medicine. This protocol potentially offers a life-saving approach to the management of hospitalized COVID-19 patients.

Dec 8, 2020
Dr. Kory Testifies to Senate Committee About I-MASK+
Dr. Pierre Kory, President of the FLCCC Alliance addresses the Senate Committee on Homeland Security and Governmental Affairs looking into earlyoutpatient COVID-19 treatment.
Watch the video on our Official Testimony page

Dec 4, 2020
FLCCC Alliance Press Conference on Ivermectin & COVID-19 in Houston, Texas and Follow-Up Press Release
FLCCC Alliance calls on national health authorities to immediately review medical evidence showing the efficacy of ivermectin for the prevention of COVID-19 and as an early outpatient treatment.
Video documentation and additional material: Electronic Press Kit for the News Conference on Dec 4, 2020